Lindy Fishburne

Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation.

Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation.

Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation.